Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis

Acta Psychiatrica Scandinavica

Volumn 114, Issue 2, 2006, Pages 109-117

  Edwards, J ^a,b,c   Elkins, K ^a   Hinton, M ^a   Harrigan, S M ^b   Donovan, K ^a   Athanasopoulos, O ^a   McGorry, P D ^a,b  

^a Early Psychosis Prevention and Intervention Centre (EPPIC)   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ORYGEN RESEARCH CENTRE   (Australia)

Author keywords

Cannabis; First episode psychosis; Psychological intervention; Randomized controlled trial; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANNABIS ADDICTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOSIS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADOLESCENT; ADULT; COMMUNITY MENTAL HEALTH SERVICES; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; SINGLE-BLIND METHOD;

EID: 33745818603     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2006.00783.x     Document Type: Article

References (41)

1. CANTWELL R, BREWIN J, GLAZEBROOK C et al. Prevalence of substance misuse in first-episode psychosis. Br J Psychiatry 1999;174:150-153.
2. LAMBERT M, CONUS P, LUBMAN DI et al. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand 2005;112:141-148.
3. SEMBHI S, LEE JWY. Cannabis use in psychotic patients. Aust N Z J Psychiatry 1999;33:529-532.
4. VAN MASTRIGT S, ADDINGTON J, ADDINGTON D. Substance misuse at presentation to an early psychosis program. Soc Psychiatry Psychiatr Epidemiol 2004;39:69-72.
5. GREEN AI, TOHEN MF, HAMER RM et al. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Schizophr Res 2004;66:125-135.
6. COLDHAM EL, ADDINGTON J, ADDINGTON D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand 2002;106:286-290.
7. KOVASZNAY B, FLEISCHER J, TANENBERG-KARANT M, JANDORF L, MILLER AD, BROMET E. Substance use disorder and the early course of illness in schizophrenia and affective psychosis. Schizophr Bull 1997;23:195-201.
8. LINSZEN DH, DINGEMANS PM, LENIOR ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994;51:273-279.
9. PENCER A, ADDINGTON J, ADDINGTON D. Outcome of a first episode of psychosis in adolescence: a 2-year follow-up. Psychiatr Res 2005;133:35-43.
10. MCCRAE AL, BUDNEY AJ, BRADY KT. Treatment of marijuana dependence: a review of the literature. J Subst Abuse Treat 2003;24:369-376.
11. ADDINGTON J, ADDINGTON D. Impact of an early psychosis program on substance use. Psychiatr Rehabil J 2001;25: 60-67.
12. KAVANAGH DJ, YOUNG R, WHITE A et al. Start over and survive: a brief intervention for substance misuse in early psychosis. In: GRAHAM H, MUESER KT, BIRCHWOOD M, COPELLO A, eds. Substance misuse in psychosis: approaches to treatment and service delivery. Chichester, Sussex: Wiley, 2003: 244-258.
13. LEY A, JEFFERY DP, MCLAREN S, SIEGFRIED N. Treatment programmes for people with both severe mental illness and substance misuse (Cochrane Review). The Cochrane Library, Issue 3. Oxford: Update Software, 2002.
14. BARROWCLOUGH C, HADDOCK G, TARRIER N et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. Am J Psychiatry 2001;158:1706-1713.
15. COPELAND J. Developments in the treatment of cannabis use disorder. Curr Opin Psychiatry 2004;17:161-167.
16. TURKINGTON D, KINGDON D, CHADWICK P. Cognitive-behavioural therapy for schizophrenia: filling the therapeutic vacuum. Br J Psychiatry 2003;183:98-99.
17. MIHALOPOULOS C, MCGORRY PD, CARTER RC. Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome? Acta Psychiatr Scand 1999;100:47-55.
18. EDWARDS J, MCGORRY PD. Implementing early intervention in psychosis. London: Martin Dunitz, 2002
19. American Psychiatric Association. Diagnostic and statistical manual for mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
20. EDWARDS J, ELKINS K, HINTON M et al. Cannabis use following initial treatment of first-episode psychosis. Schizophr Res 2001;49(suppl. 1):12-13.
21. EDWARDS J, HINTON M, ELKINS K, ANTHANASOPOULOS O. Cannabis and first-episode psychosis: The CAP Project. In: GRAHAM H, MUESER KT, BIRCHWOOD M, COPELLO A, eds. Substance misuse in psychosis: approaches to treatment and service delivery. Chichester, Sussex: Wiley, 2003: 283-304.
22. MILLER WM, ROLLNICK S. Motivational interviewing: preparing people to change addictive behaviour. New York: Guilford Press, 2002.
23. PROCHASKA JO, DICLEMENTE CC. Stages of change in the modification of problem behaviours. In: HERSEN M, ed. Progress in behaviour modification. New York: Sycamore, 1992: 183-218.
24. HINTON M, ELKINS K, EDWARDS J, DONOVAN K. Cannabis and psychosis treatment manual. Melbourne: Early Psychosis Prevention and Intervention Centre, 2002.
25. MCGORRY PD, EDWARDS J, MIHALOPOULOS C, HARRIGAN SM, JACKSON HJ. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996;22:305-326.
26. FIRST MB, GIBBON M, SPITZER RL, WILLIAMS JBW. Structured clinical interview for DSM-IV axis I disorders - research version, patient edition with psychotic screen. New York: Biometrics Research Department, New York State Psychiatric Institute, 1996.
27. WING JK, BABOR T, BRUGHA T et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 1990;47:589-593.
28. MCLELLAN AT, LUBORSKY L, CACCIOLA J et al. New data from the Addiction Severity Index. Reliability and validity in three centers. J Nerv Ment Dis 1985;173:412-423.
29. ROLLNICK S, HEATHER N, GOLD R, HALL W. Development of a short 'readiness to change' questionnaire for use in brief, opportunistic interventions among excessive drinkers. Br J Addiction 1992;87:743-754.
30. LUKOFF D, NEUCHTERLEIN KH, VENTURA J. Manual for the Expanded Brief Psychiatric Rating Scale. Schizophr Bull 1986;12:594-602.
31. ANDREASEN NC. Scale for the assessment of negative symptoms (SANS). Iowa City, IA: University of Iowa, 1984.
32. BECK AT, BECK RW. Screening depressed patients in family practice. A rapid technique. Postgrad Med 1972;52:81-85.
33. GOLDMAN HH, SKODOL AE, LAVE TR. Revising axis V for DSM-IV: a review of measures of social functioning. Am J Psychiatry 1992;149:1148-1156.
34. BIRCHWOOD M, SMITH J, COCHRANE R. Specific and non-specific effects of educational intervention for families living with schizophrenia. A comparison of three methods. Br J Psychiatry 1992;160:806-814.
35. BUDNEY AJ, HIGGINS ST, RADONOVICH KJ, NOVY PL. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol 2000;68:1051-1061.
36. BERSANI G, ORLANDI V, KOTZALIDIS GD, PANCHERI P. Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes. Eur Arch Psychiatry Clin Neurosci 2002;252:86-92.
37. COHEN J. A power primer. Psychol Bull 1992;112:155-159.
38. BAKER A, LEWIN T, REICHLER H et al. Motivational interviewing among psychiatric in-patients with substance use disorders. Acta Psychiatr Scand 2002;106:233-240.
39. COPELAND J, SWIFT W, ROFFMAN R, STEPHENS R. A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. J Subst Abuse Treat 2001;21:55-64.
40. The Marijuana Treatment Project Research Group.Brief treatments for cannabis dependence: findings from a randomized multisite trial. J Consult Clin Psychol 2004;72:455-466.
41. SENSKY T, TURKINGTON D, KINGDON D et al. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Arch Gen Psychiatry 2000;57:165-172.